[Antimicrobial effect of the new oral antidiabetic HB 419].
D001419:Bacteria / Q000187:drug effects*; D001439:Bacteroides / Q000187:drug effects; D001786:Blood Glucose / Q000032:analysis; D002175:Candida / Q000187:drug effects; D003016:Clostridium perfringens / Q000187:drug effects; D003353:Corynebacterium diphtheriae / Q000187:drug effects; D003864:Depression, Chemical; D004754:Enterobacter / Q000187:drug effects; D013293:Enterococcus faecalis / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007709:Klebsiella / Q000187:drug effects; D007778:Lactobacillus / Q000187:drug effects; D007779:Lactobacillus acidophilus / Q000187:drug effects; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012475:Salmonella / Q000187:drug effects; D012485:Salmonella typhi / Q000187:drug effects; D012762:Shigella dysenteriae / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects; D014508:Urea / Q000494:pharmacology*
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D014508:Urea
Zur Frage einer antimikrobiellen Wirkung des neuen oralen Antidiabeticums HB 419.